ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

The Efficacy of Low Dose Steroid Therapy for Postoperative Hyperbilirubinemia in Liver Transplant Recipients: A Prospective Randomized Controlled Trial

J. Yang, X. He, L. Wu, Z. Guo.

Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Meeting: 2018 American Transplant Congress

Abstract number: C211

Keywords: Graft function

Session Information

Date: Monday, June 4, 2018

Session Name: Poster Session C: Liver: Immunosuppression and Rejection

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Related Abstracts
  • 1-Year Outcomes of a Prospective, Open Label, Randomized, Controlled Trial of Standard vs Extended-Release Tacrolimus as Maintenance Monotherapy in Kidney Transplantation after Alemtuzumab Induction with Rapid Steroid Withdrawal (TAESR Trial)
  • Steroid Withdrawal and De Novo Donor-Specific HLA Antibodies in Renal Transplant Patients: A Prospective, Randomized, Controlled Study in Parallel Groups. Preliminary Results.

Background: Hyperbilirubinemia is a common but reversible event after liver transplantation . Steroids is a widely used anti-inflammatory agent, which may help improve allograft function, but limited study analysis the effect of steroid in post-transplantation hyperbilirubinemia. The aim of the study was to evaluate whether steroid therapy was benefit to hyperbilirubinemia. Methods: In our center, immunosuppression therapy adopted tacrolimus with basiliximab induction and steroids avoidance protocols. Postoperative hyperbilirubinemia patients (excluded biliary and vascular complications, rejections, etc.) were randomly assigned to steroid or control group. Patients in steroid group were treated by 1 mg/kg of methylprednisolone for 5 days combined with ursodeoxycholic acid (UDCA), the control group were only treated by UDCA. The primary end point was the trajectories of serum total bilirubin (TBIL) within the first two week after assignment. Results: Steroid group included 20 recipients, 10 in the control group. The data of donors, recipients and operation were not different between two groups. After 5-days treatment, mean TBIL levels decreased from 17.7 ± 8.3 mg/L to 10.1 ± 7.0 mg/L, however, TBIL increased from 13.8 ± 4.1 mg/L to 14.9 ± 4.4 mg/L in the control group ( and ), which showed a significant difference on the trend of TBIL (decreased 7.6 ± 8.7 mg/L vs. increased 1.1 ± 4.2 mg/L, respectively, P=0.006). Moreover, after 5-days treatment the increase of prealbumin in steroid group significantly faster than the control group(73.0 ± 46.3 vs. 17.3 ± 42.0 mg/L, respectively, P=0.003).Neither serious infection nor ulcer were found during steroid treatment. Conclusions:Low dose steroid therapy may accelerate the recovery of hyperbilirubinemia in liver transplantation.

CITATION INFORMATION: Yang J., He X., Wu L., Guo Z. The Efficacy of Low Dose Steroid Therapy for Postoperative Hyperbilirubinemia in Liver Transplant Recipients: A Prospective Randomized Controlled Trial Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yang J, He X, Wu L, Guo Z. The Efficacy of Low Dose Steroid Therapy for Postoperative Hyperbilirubinemia in Liver Transplant Recipients: A Prospective Randomized Controlled Trial [abstract]. https://atcmeetingabstracts.com/abstract/the-efficacy-of-low-dose-steroid-therapy-for-postoperative-hyperbilirubinemia-in-liver-transplant-recipients-a-prospective-randomized-controlled-trial/. Accessed January 25, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.